|
Details
|
Specifications
|
|---|---|
|
CAS Number
|
1140909-48-3
|
|
Molecular Formula
|
C28H24FN3O5.C4H6O5
|
|
Molecular Weight
|
635.6 g/mol.
|
|
Synonyms
|
Cabozantinib S malate
|
|
Chemical Name
|
N-(4-(6,7-dimethoxyquinolin-4-yloxy) phenyl)-N?-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate
|
|
Therapeutic use
|
COMETRIQ is a kinase inhibitor indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC).
|
|
Status
|
Tech pack available
|
|
Background
|
Cabozantinib (S)-malate used as a targeted therapy for several advanced cancers. It acts by inhibiting receptors involved in tumor growth, angiogenesis (new blood vessel formation), and metastasis, It was developed by Exelixis Inc. and is marketed under two main brand names for different indications: Cabometyx (tablets) and Cometriq (capsules)
|
|
Grade
|
In-house
|
|
Polymorph
|
--
|
|
Storage Temperature
|
Controlled room temperature (20?C ? 25?C)
|
Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*Â
Disclaimer:Â
The information provided on this webpage is based on the best available knowledge at the time of publication; however, accuracy and completeness are not guaranteed. Product specifications may change without notice. It is the responsibility of the purchaser or user to verify suitability and compliance. This product is intended for research use only and is not approved for human consumption.
Happy Customers
Projects Successfully Completed
Established
PhD Experts Driving R&D Excellence
Team Size
World-Class API Manufacturing Sites
Global Audits Successfully Completed
Comprehensive CDMO Service Offerings
Everything You Need to Know About Shilpa Pharma
Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*
